Search by Drug Name or NDC

NDC 50405-0300-01 Levetiracetam 250 mg/1 Details

Levetiracetam 250 mg/1

Levetiracetam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by SOHM, Inc.. The primary component is LEVETIRACETAM.

MedlinePlus Drug Summary

Levetiracetam is used alone and along with other medications to control partial-onset seizures (seizures that involve only one part of the brain) in adults, children, and infants 1 month of age or older. Levetiracetam is also used in combination with other medications to treat seizure in adults and children 12 years of age or older with juvenile myoclonic epilepsy. Levetiracetam is also used in combination with other medications to treat primary generalized tonic-clonic seizures (formerly known as a grand mal seizure; seizure that involves the entire body) in adults and children 6 years of age or older with epilepsy. Levetiracetam is in a class of medications called anticonvulsants. It works by decreasing abnormal excitement in the brain.

Related Packages: 50405-0300-01
Last Updated: 04/14/2024
MedLinePlus Full Drug Details: Levetiracetam

Product Information

NDC	50405-0300
Product ID	50405-300_f38a03a2-39ba-44ec-9f1d-b63e5f11ce58
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Levetiracetam
Proprietary Name Suffix	n/a
Non-Proprietary Name	Levetiracetam
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET
Route	ORAL
Active Ingredient Strength	250
Active Ingredient Units	mg/1
Substance Name	LEVETIRACETAM
Labeler Name	SOHM, Inc.
Pharmaceutical Class	Decreased Central Nervous System Disorganized Electrical Activity [PE]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA079042
Listing Certified Through	2024-12-31

Package

NDC 50405-0300-01 (50405030001)

Pricing Information	N/A
NDC Package Code	50405-300-01
Billing NDC	50405030001
Package	30 TABLET in 1 BOTTLE (50405-300-01)
Marketing Start Date	2023-05-01
NDC Exclude Flag	N